Skip to main content
. 2022 Mar 15;12:835559. doi: 10.3389/fonc.2022.835559

Figure 1.

Figure 1

Flowchart to select eligible HCC patients with BDTT for the study. HCC, hepatocellular carcinoma; BDTT, bile duct tumor thrombus; LR, liver resection; TACE, transcatheter arterial chemoembolization; RFA, radiofrequency ablation; RT, radiation therapy; PSM, propensity score matching.